Vidhi Specialty Food Ingredients Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:25 pm

Quick Insight

Vidhi Specialty Food Ingredients Ltd, with a market capitalization of ₹1,904 Cr. and a price of 378, is trading at a P/E ratio of 39.8, reflecting investor confidence in its future earnings potential. The company's ROE stands at a respectable 14.9%, indicating efficient utilization of shareholder funds, while the ROCE of 18.7% signals strong operational performance. With a healthy OPM of 23% and a net profit of ₹44 Cr., Vidhi is demonstrating profitability in its operations. Its low borrowings of ₹66 Cr. and impressive ICR of 28.25x indicate a strong financial position. However, the high P/BV ratio of 7.56x suggests the stock may be overvalued. Investors should closely monitor operational efficiency and earnings growth to assess long-term sustainability.

Competitors of Vidhi Specialty Food Ingredients Ltd

All Competitor Stocks of Vidhi Specialty Food Ingredients Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:25 am

Below is a detailed analysis of the quarterly data for Vidhi Specialty Food Ingredients Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 88.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2025) to 88.00 Cr., marking a decrease of 22.00 Cr..
• For Expenses, as of Jun 2025, the value is 67.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 90.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 23.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 23.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Mar 2025) to 23.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Mar 2025) to 26.00%, marking a decrease of 6.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.55. The value appears strong and on an upward trend. It has increased from 2.41 (Mar 2025) to 2.55, marking an increase of 0.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:50 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 3:05 pm

Below is a detailed analysis of the balance sheet data for Vidhi Specialty Food Ingredients Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 297.00 Cr.. The value appears strong and on an upward trend. It has increased from 276.00 Cr. (Mar 2024) to 297.00 Cr., marking an increase of 21.00 Cr..
• For Borrowings, as of Mar 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20.00 Cr. (Mar 2024) to 66.00 Cr., marking an increase of 46.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 397.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 325.00 Cr. (Mar 2024) to 397.00 Cr., marking an increase of 72.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 258.00 Cr.. The value appears strong and on an upward trend. It has increased from 187.00 Cr. (Mar 2024) to 258.00 Cr., marking an increase of 71.00 Cr..
• For Total Assets, as of Mar 2025, the value is 397.00 Cr.. The value appears strong and on an upward trend. It has increased from 325.00 Cr. (Mar 2024) to 397.00 Cr., marking an increase of 72.00 Cr..

Notably, the Reserves (297.00 Cr.) exceed the Borrowings (66.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Vidhi Specialty Food Ingredients Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 8.68, marking an increase of 1.37.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 8.68, marking an increase of 1.37.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.19. This value is within the healthy range. It has increased from 8.53 (Mar 24) to 10.19, marking an increase of 1.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 60.19. It has increased from 56.02 (Mar 24) to 60.19, marking an increase of 4.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 60.19. It has increased from 56.02 (Mar 24) to 60.19, marking an increase of 4.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 76.43. It has increased from 60.66 (Mar 24) to 76.43, marking an increase of 15.77.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.01. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 14.01, marking an increase of 2.37.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.49. This value is within the healthy range. It has increased from 10.39 (Mar 24) to 12.49, marking an increase of 2.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.99. This value is within the healthy range. It has increased from 9.76 (Mar 24) to 11.99, marking an increase of 2.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.68, marking an increase of 1.39.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.68, marking an increase of 1.39.
• For PBDIT Margin (%), as of Mar 25, the value is 18.32. This value is within the healthy range. It has decreased from 19.18 (Mar 24) to 18.32, marking a decrease of 0.86.
• For PBIT Margin (%), as of Mar 25, the value is 16.33. This value is within the healthy range. It has decreased from 17.13 (Mar 24) to 16.33, marking a decrease of 0.80.
• For PBT Margin (%), as of Mar 25, the value is 15.69. This value is within the healthy range. It has decreased from 16.08 (Mar 24) to 15.69, marking a decrease of 0.39.
• For Net Profit Margin (%), as of Mar 25, the value is 11.35. This value exceeds the healthy maximum of 10. It has decreased from 12.01 (Mar 24) to 11.35, marking a decrease of 0.66.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.35. This value is within the healthy range. It has decreased from 12.01 (Mar 24) to 11.35, marking a decrease of 0.66.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.41. This value is below the healthy minimum of 15. It has increased from 13.00 (Mar 24) to 14.41, marking an increase of 1.41.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.17. This value is within the healthy range. It has increased from 18.20 (Mar 24) to 20.17, marking an increase of 1.97.
• For Return On Assets (%), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 11.23 (Mar 24) to 10.95, marking a decrease of 0.28.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.21, marking an increase of 0.14.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has increased from 0.92 (Mar 24) to 1.06, marking an increase of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 2.92. This value is within the healthy range. It has decreased from 4.79 (Mar 24) to 2.92, marking a decrease of 1.87.
• For Quick Ratio (X), as of Mar 25, the value is 2.05. This value exceeds the healthy maximum of 2. It has decreased from 3.35 (Mar 24) to 2.05, marking a decrease of 1.30.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 4. It has increased from 2.91 (Mar 24) to 3.27, marking an increase of 0.36.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 19.18 (Mar 24) to 0.00, marking a decrease of 19.18.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.38 (Mar 24) to 0.00, marking a decrease of 16.38.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 80.82 (Mar 24) to 0.00, marking a decrease of 80.82.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.62 (Mar 24) to 0.00, marking a decrease of 83.62.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 28.25. This value is within the healthy range. It has increased from 18.28 (Mar 24) to 28.25, marking an increase of 9.97.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 18.50. This value is within the healthy range. It has increased from 12.45 (Mar 24) to 18.50, marking an increase of 6.05.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,312.58. It has increased from 2,279.94 (Mar 24) to 2,312.58, marking an increase of 32.64.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.05. This value exceeds the healthy maximum of 3. It has decreased from 7.51 (Mar 24) to 6.05, marking a decrease of 1.46.
• For EV / EBITDA (X), as of Mar 25, the value is 33.01. This value exceeds the healthy maximum of 15. It has decreased from 39.17 (Mar 24) to 33.01, marking a decrease of 6.16.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has decreased from 7.49 (Mar 24) to 5.95, marking a decrease of 1.54.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 80.81 (Mar 24) to 0.00, marking a decrease of 80.81.
• For Price / BV (X), as of Mar 25, the value is 7.56. This value exceeds the healthy maximum of 3. It has decreased from 8.11 (Mar 24) to 7.56, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has decreased from 7.49 (Mar 24) to 5.95, marking a decrease of 1.54.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness